Precision BioSciences Inc (NASDAQ:DTIL)
| 1.74 Delayed Data As of May 19 |  -0.05 / -2.81%Today’s Change | 1.49 Today|||52-Week Range 14.38 | -76.49% Year-to-Date |
Latest DTIL News | Press Releases
| Caribou Charges Ahead on Study Results May 17 / GuruFocus News - Paid Partner Content | Precision BioSciences (DTIL) Reports Q1 Loss, Misses Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.78 |
| Today’s open | 1.75 |
| Day’s range | 1.68 - 1.81 |
| Volume | 553,914 |
| Average volume (3 months) | 671,417 |
| Market cap | $98.9M |
Data as of 4:03pm ET, 05/19/2022
Growth & Valuation
| Earnings growth (last year) | +75.11% |
| Earnings growth (this year) | -242.73% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +375.72% |
| P/E ratio | NM |
| Price/Sales | 3.76 |
| Price/Book | 1.06 |
Competitors
| ---- | ||
| VBLTVascular Biogenics L... | -0.02 | -1.27% |
| SURFSurface Oncology Inc | -0.01 | -0.51% |
| LPTXLeap Therapeutics In... | -0.01 | -0.82% |
Data as of 4:03pm ET, 05/19/2022
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $115.5M |
| Annual profit (last year) | -$30.6M |
| Net profit margin | -26.49% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
